ASRS

An unusual clinical trial design to test vision restoration in GA

Patient-reported outcomes with MCO-010 in retinitis pigmentosa

Microsecond laser's role in treating chronic CSCR

QUASAR 64-week results: aflibercept 8 mg in macular edema following RVO—Jordana G. Fein, MD, MS

How OLN324 differs from faricimab

Where does the field stand on functional outcomes in geographic atrophy?

How do baseline vision-loss predictors from the ARCHER study change GA patient counseling?

AXPAXLI's real-world potential to reduce wet AMD treatment gaps

AI's future role in retina care recordkeeping, imaging, and research

Which baseline characteristics predict vision loss in geographic atrophy?